Please login to be able to save your searches and receive alerts for new content matching your search criteria.
This article reveals the current status of biotechnology industry in Taiwan.
Biogen Idec's Aducanumab (BIIB037) shown to reduce brain amyloid plaque levels slow cognitive decline in patients with prodromal or mild Alzheimer's disease.
Johnson Matthey recognized in 2015 CMO Leaderships Awards.
Heraeus enters agreement to acquire NeoMetrics.
AstraZeneca and Daiichi Sankyo to jointly commercialize MOVANTIK in the US.
AbbVie and C2N enter worldwide license agreement for Alzheimer's disease therapy.
Menara Landmark Medical Suites expands healthcare and medical offerings in Johor Bahru.
Sigma-Aldrich® expands customer-centric model with investments in Singapore.
NTU setting up a new $30 million institute to boost Singapore's efforts in tackling human disease.